Article
Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31.
British journal of haematology - 1 Sept 2024
Liu Linlin, Li Bing, Xu Zefeng, Qin Tiejun, Jia Yujiao, Qu Shiqiang, Zhang Yudi, Wu Junying, Cai Wenyu, Pan Lijuan, Gao Qingyan, Jiao Meng, Xiao Zhijian
Abstract excerpt
The criteria of myelodysplastic syndromes (MDS) with mutated SFB31 (MDS-SFB31) proposed by the 5th edition of the WHO classification (WHO 2022) and the International Consensus Classification (ICC) need validation. We analysed 125 consecutive MDS cases with SFB31 mutation or ring sideroblasts (RS) ≥15% without excess blasts. We found that SFB31-negative MDS with RS had significantly different clinical features and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.